Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. REAX
REAX logo

REAX Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
2.250
Open
2.230
VWAP
2.11
Vol
5.73M
Mkt Cap
437.78M
Low
2.030
Amount
12.08M
EV/EBITDA(TTM)
--
Total Shares
214.60M
EV
374.77M
EV/OCF(TTM)
5.12
P/S(TTM)
2.66
The Real Brokerage Inc. is a real estate technology company that operates as a software-based brokerage across approximately 50 states in United Stated, the District of Columbia, and four Canadian provinces. Its platform leverages artificial intelligence (AI) and automation to enhance agent productivity while maintaining a lean operating model. The Company operates as a fully digital brokerage, offering agents a more flexible, efficient, and financially compelling model. Its technology platform is reZEN, is a proprietary transaction management and brokerage operations software. The Company’s services include end-to-end transaction management, automated compliance & brokerage oversight, integrated payment & financial services, Leo CoPilot: AI-powered agent support, and open application programming interface (API) for customization.
Show More

Events Timeline

(ET)
2026-05-07
07:20:00
Real Reports Q1 Revenue of $465.6M, Acquires RE/MAX
select
2026-04-27 (ET)
2026-04-27
07:20:00
Real Brokerage Acquires RE/MAX Holdings in $880M Deal
select
2026-04-27
07:20:00
Real Brokerage to Acquire Re/Max Holdings for $13.80 per Share
select
2026-04-22 (ET)
2026-04-22
07:40:00
Real Brokerage Acquires Solutions Group, Adding $300M in Annual Sales
select
2026-04-09 (ET)
2026-04-09
07:40:00
Real Brokerage Welcomes Team Jordan Led by Lorraine Jordan
select
2026-04-07 (ET)
2026-04-07
07:40:00
Real Brokerage Acquires Arizona Real Estate Team
select

News

Globenewswire
8.5
05-05Globenewswire
Investigation Alerts for Multiple Company Mergers
  • XOMA Acquisition Deal: XOMA Royalty Corporation is set to be acquired by Ligand Pharmaceuticals for $39.00 per share, totaling approximately $739 million; however, this price is below its 52-week high of $42.38, raising concerns among shareholders about the fairness of the transaction.
  • Organon Merger Case: Organon & Co. will be acquired by Sun Pharmaceutical for $14.00 per share, with an enterprise valuation of $11.75 billion, and the investigation focuses on whether the Organon Board failed to uphold fiduciary duties to ensure a fair process for shareholders.
  • RE/MAX Merger Investigation: RE/MAX Holdings, Inc. is being acquired by The Real Brokerage Inc., allowing shareholders to choose between 5.152 shares of the new company or $13.80 in cash, with investigations looking into whether the Board adequately handled the transaction to protect shareholder interests.
  • Soleno Acquisition Case: Soleno Therapeutics, Inc. will be acquired by Neurocrine Biosciences for $53.00 per share, representing a total equity value of approximately $2.9 billion, while the investigation questions whether the Board ensured the deal was fair to shareholders, given that the price is below its 52-week high of $90.32.
PRnewswire
7.0
04-27PRnewswire
Investor Rights Law Firm Investigates Multiple Companies
  • Legal Investigation Launched: Halper Sadeh LLC is investigating Organon & Co. (NYSE:OGN) regarding its sale to Sun Pharmaceutical Industries Limited for $14.00 per share, which may involve breaches of fiduciary duties impacting shareholder confidence and company reputation.
  • RE/MAX Transaction Scrutiny: The sale of RE/MAX Holdings, Inc. (NYSE:RMAX) to The Real Brokerage Inc. offers either 5.152 shares or $13.80 in cash per share, potentially limiting superior competing offers, prompting shareholders to consider their rights and options.
  • XOMA Transaction Risks: XOMA Royalty Corporation (NASDAQ:XOMA) is involved in a sale to Ligand Pharmaceuticals Incorporated for $39.00 per share, with Halper Sadeh LLC possibly seeking increased compensation for shareholders, affecting the future shareholder structure of the company.
  • Merger Impact Analysis: The merger between The Real Brokerage Inc. (NASDAQ:REAX) and RE/MAX will result in Real shareholders owning approximately 59% of the combined entity, potentially altering the competitive landscape and necessitating a reassessment of shareholder rights and risks post-merger.
Globenewswire
8.5
04-27Globenewswire
Investigation Alerts for Multiple Mergers
  • XOMA Acquisition Deal: XOMA Royalty Corporation is set to be acquired by Ligand Pharmaceuticals for $39.00 per share, totaling approximately $739 million; however, this price is below its 52-week high of $42.38, raising concerns among shareholders about the fairness of the transaction.
  • Organon Merger Case: Organon & Co. will be acquired by Sun Pharmaceutical for $14.00 per share in cash, with an enterprise valuation of $11.75 billion, and the investigation focuses on whether the Organon Board failed to treat shareholders fairly, potentially impacting shareholder rights.
  • RE/MAX Acquisition Proposal: RE/MAX Holdings, Inc. will be acquired by The Real Brokerage, allowing shareholders to choose between 5.152 shares of the new company or $13.80 in cash per share, with investigations into whether the Board failed to handle the transaction fairly, affecting shareholder interests.
  • Soleno Acquisition Investigation: Soleno Therapeutics, Inc. will be acquired by Neurocrine Biosciences for $53.00 per share, representing a total transaction value of approximately $2.9 billion, but this price is below its 52-week high of $90.32, raising questions about the Board's fairness in the deal.
seekingalpha
8.5
04-27seekingalpha
Real Brokerage Confirms Acquisition of RE/MAX for $880M
  • Transaction Value Confirmation: Real Brokerage (REAX) has confirmed the acquisition of RE/MAX (RMAX) for an enterprise value of approximately $880 million, representing a fully synergized multiple of 7x 2025 EBITDA, which is expected to enhance Real's profitability and adjusted EBITDA margin.
  • Shareholder Options: RE/MAX shareholders can elect to receive either 5.15 shares of Real REMAX Group or $13.80 in cash per share, with total cash proceeds to RE/MAX investors expected to be no less than $60 million and no greater than $80 million, demonstrating strong appeal to shareholders.
  • Post-Merger Structure: Following the merger, Real shareholders are expected to own about 59% of the new entity, while RE/MAX investors will hold approximately 41%, with the new company named Real REMAX Group and set to trade on NASDAQ, further enhancing market competitiveness.
  • Business Synergies: The acquisition is anticipated to generate about $30 million in annual run-rate cost savings, combining Real's brokerage platform with RE/MAX's expansive global franchise network, resulting in a robust team of approximately 8,500 franchisees and over 180,000 agents, driving future business growth.
stocktwits
8.5
04-27stocktwits
RE/MAX Merges with The Real Brokerage, Creating Real REMAX Group
  • Shareholder Options: RE/MAX shareholders can choose to receive either 5.152 shares of the new company or $13.80 in cash per share, representing a roughly 72% premium over Friday's closing price, indicating strong market confidence in the merger and expected enhancement of shareholder value.
  • Leadership Structure: Tamir Poleg, the current CEO of The Real Brokerage, will serve as chairman and CEO of the merged entity, Real REMAX Group, which is expected to leverage its AI-driven brokerage model alongside RE/MAX's established global franchise network to enhance operational efficiency.
  • Financial Outlook: The merger is projected to generate approximately $2.3 billion in annual revenue and $157 million in adjusted earnings on a pro forma basis by 2025, indicating that the merger will significantly boost the company's profitability and margins, thereby strengthening its competitive position.
  • Positive Market Reaction: Following the merger announcement, RE/MAX shares surged over 20% in pre-market trading, reflecting investor optimism about the merger, while shareholder expectations for future growth continue to rise.
seekingalpha
8.5
04-27seekingalpha
RE/MAX Stock Surges 15% on $550M Sale to The Real Brokerage
  • Stock Surge: RE/MAX (RMAX) shares jumped approximately 15% during pre-market trading on Monday, reflecting market optimism regarding its impending sale to tech-focused real estate firm The Real Brokerage (REAX) valued at $550 million.
  • Significant Transaction Value: The deal is estimated at around $550 million, with total transaction value, including debt, projected to reach approximately $880 million, underscoring RE/MAX's strong position and appeal in the real estate market.
  • Shareholder Options: RE/MAX shareholders will have the option to receive either 5.15 shares of the new combined entity or $13.80 in cash for each share they own, a flexible choice that is likely to attract more investor participation and bolster shareholder confidence.
  • Post-Merger Leadership: The combined entity will be led by Real Brokerage CEO Tamir Poleg as chairman and CEO, while both the RE/MAX and Real brands will continue to operate, ensuring the continuity of brand value and market influence.
Wall Street analysts forecast REAX stock price to rise
3 Analyst Rating
Wall Street analysts forecast REAX stock price to rise
3 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
6.00
Averages
7.00
High
8.00
Current: 0.000
sliders
Low
6.00
Averages
7.00
High
8.00
B. Riley
Naved Khan
Buy
to
Buy
downgrade
$8 -> $7
AI Analysis
2026-05-08
New
Reason
B. Riley
Naved Khan
Price Target
$8 -> $7
AI Analysis
2026-05-08
New
downgrade
Buy
to
Buy
Reason
B. Riley analyst Naved Khan lowered the firm's price target on Real Brokerage to $7 from $8 and keeps a Buy rating on the shares. The firm views the company's Q1 report as strong.
BTIG
Jake Fuller
Buy
maintain
$4.25
2026-04-27
Reason
BTIG
Jake Fuller
Price Target
$4.25
2026-04-27
maintain
Buy
Reason
BTIG analyst Jake Fuller views Real Brokerage's (REAX) acquisition of Re/Max Holdings (RMAX) as a "strategic plus" at an "appealing valuation." Real Brokerage is gaining scale and relevance in a consolidating industry at the bottom of the cycle, the analyst tells investors in a research note. BTIG believes the deal will diversify the company's revenue and add a high-margin franchise business. It keeps a By rating on Real Brokerage with a $4.25 price target. The stock in late morning trading is down 27% to $1.95.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for REAX
Unlock Now

Valuation Metrics

The current forward P/E ratio for Real Brokerage Inc (REAX.O) is 0.00, compared to its 5-year average forward P/E of -40.11. For a more detailed relative valuation and DCF analysis to assess Real Brokerage Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-40.11
Current PE
0.00
Overvalued PE
1.26
Undervalued PE
-81.47

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-41.51
Current EV/EBITDA
-25.19
Overvalued EV/EBITDA
109.70
Undervalued EV/EBITDA
-192.72

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
0.83
Current PS
0.17
Overvalued PS
1.54
Undervalued PS
0.11

Financials

AI Analysis
Annual
Quarterly

Related Community Screener

pennie stocks to trade
Intellectia · 83 candidates
Price: $1.00 - $5.00Volume: >= 1,000,000Relative Vol: >= 1.50Beta: HighRiskMoving Average Relationship: PriceAboveMA20, PriceAboveMA5, PriceCrossAboveMA5
Ticker
Name
Market Cap$
top bottom
RXT logo
RXT
Rackspace Technology Inc
565.74M
RDZN logo
RDZN
Roadzen Inc
146.58M
INO logo
INO
Inovio Pharmaceuticals Inc
101.17M
SABR logo
SABR
Sabre Corp
723.17M
ZVIA logo
ZVIA
Zevia PBC
91.54M
GENI logo
GENI
Genius Sports Ltd
1.13B
stock picker
Intellectia · 11 candidates
Market Cap: 200.00M - 10.00BQuarter Revenue Yoy Growth: >= 10.0%Market Cap Category: mid, smallRevenue 5yr Cagr: >= 20Debt Equity: <= 1List Exchange: XNAS
Ticker
Name
Market Cap$
top bottom
REAX logo
REAX
Real Brokerage Inc
568.96M
SOUN logo
SOUN
SoundHound AI Inc
3.49B
BCYC logo
BCYC
Bicycle Therapeutics PLC
337.89M
GCT logo
GCT
GigaCloud Technology Inc
1.71B
OPRA logo
OPRA
Opera Ltd
1.55B
XPEL logo
XPEL
Xpel Inc
1.29B
find a stock that could rise 1000%
Intellectia · 20 candidates
Market Cap: 300.00M - 5.00BQuarter Revenue Yoy Growth: >= 40.0%Beta: HighRiskRevenue 5yr Cagr: >= 25List Exchange: XNYS, XNAS, XASETarget Price Upside Potential: MoreAbovePrice
Ticker
Name
Market Cap$
top bottom
TGTX logo
TGTX
TG Therapeutics Inc
4.84B
MARA logo
MARA
MARA Holdings Inc
3.76B
LCID logo
LCID
Lucid Group Inc
3.58B
CRMD logo
CRMD
CorMedix Inc
628.74M
REAX logo
REAX
Real Brokerage Inc
766.72M
PRCT logo
PRCT
Procept Biorobotics Corp
1.61B
focus on growth and value
Intellectia · 28 candidates
Market Cap: >= 500.00MPrice: <= $5.00Revenue 5yr Cagr: >= 15Pe Ttm: <= 15
Ticker
Name
Market Cap$
top bottom
NIO logo
NIO
NIO Inc
11.55B
CSAN logo
CSAN
Cosan SA
4.02B
FUBO logo
FUBO
FuboTV Inc
3.33B
PLUG logo
PLUG
Plug Power Inc
3.09B
RXRX logo
RXRX
Recursion Pharmaceuticals Inc
2.40B
CLVT logo
CLVT
Clarivate PLC
1.86B
any penny stock?
Intellectia · 72 candidates
Market Cap: 50.00M - 2.00BPrice: <= $5.00Beta: ModerateRisk, HighRiskWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 10.0%
Ticker
Name
Market Cap$
top bottom
BITF logo
BITF
Bitfarms Ltd
1.61B
BORR logo
BORR
Borr Drilling Ltd
1.34B
TUYA logo
TUYA
Tuya Inc
1.31B
TBLA logo
TBLA
Taboola.com Ltd
1.18B
BFLY logo
BFLY
Butterfly Network Inc
1.12B
ASST logo
ASST
Strive Inc
1.11B
penny stocks that will boom
Intellectia · 104 candidates
Market Cap: <= 2.00BPrice: <= $5.00Quarter Revenue Yoy Growth: >= 0.0%Quarter Eps Yoy Growth: >= 0.0%Weekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
MQ logo
MQ
Marqeta Inc
1.94B
BORR logo
BORR
Borr Drilling Ltd
1.34B
PSEC logo
PSEC
Prospect Capital Corp
1.33B
PLTK logo
PLTK
Playtika Holding Corp
1.32B
TUYA logo
TUYA
Tuya Inc
1.31B
TBLA logo
TBLA
Taboola.com Ltd
1.18B
beat penny stocks
Intellectia · 34 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Quarter Revenue Yoy Growth: >= 20.0%Beta: HighRiskWeekly Average Turnover: >= 1,000,000
Ticker
Name
Market Cap$
top bottom
EVGO logo
EVGO
EVgo Inc
951.67M
BLDP logo
BLDP
Ballard Power Systems Inc
784.93M
REAX logo
REAX
Real Brokerage Inc
781.54M
HIVE logo
HIVE
HIVE Digital Technologies Ltd
768.63M
PRME logo
PRME
Prime Medicine Inc
723.85M
BTBT logo
BTBT
Bit Digital Inc
721.79M
give me a list of pennies stock
Intellectia · 161 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
IOVA logo
IOVA
Iovance Biotherapeutics Inc
996.39M
MVST logo
MVST
Microvast Holdings Inc
951.73M
EVGO logo
EVGO
EVgo Inc
951.67M
WOOF logo
WOOF
Petco Health and Wellness Company Inc
935.06M
INDI logo
INDI
indie Semiconductor Inc
933.44M
LDI logo
LDI
loanDepot Inc
893.07M
penny stocks to buy
Intellectia · 161 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Is Optionable: True
Ticker
Name
Market Cap$
top bottom
IOVA logo
IOVA
Iovance Biotherapeutics Inc
996.39M
MVST logo
MVST
Microvast Holdings Inc
951.73M
EVGO logo
EVGO
EVgo Inc
951.67M
WOOF logo
WOOF
Petco Health and Wellness Company Inc
935.06M
INDI logo
INDI
indie Semiconductor Inc
933.44M
LDI logo
LDI
loanDepot Inc
893.07M
show me good penny stocks
Intellectia · 41 candidates
Market Cap: <= 1000.00MPrice: <= $5.00Beta: HighRiskWeekly Average Turnover: >= 1,000,000Annual Revenue Yoy Growth: >= 20.0%
Ticker
Name
Market Cap$
top bottom
IOVA logo
IOVA
Iovance Biotherapeutics Inc
996.39M
MVST logo
MVST
Microvast Holdings Inc
951.73M
EVGO logo
EVGO
EVgo Inc
951.67M
REAX logo
REAX
Real Brokerage Inc
781.54M
URG logo
URG
Ur-Energy Inc
726.09M
BTBT logo
BTBT
Bit Digital Inc
721.79M

Whales Holding REAX

I
Insight Venture Management, LLC
Holding
REAX
+21.62%
3M Return
P
Portolan Capital Management, LLC
Holding
REAX
+16.97%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Real Brokerage Inc (REAX) stock price today?

The current price of REAX is 2.04 USD — it has decreased -8.52

What is Real Brokerage Inc (REAX)'s business?

The Real Brokerage Inc. is a real estate technology company that operates as a software-based brokerage across approximately 50 states in United Stated, the District of Columbia, and four Canadian provinces. Its platform leverages artificial intelligence (AI) and automation to enhance agent productivity while maintaining a lean operating model. The Company operates as a fully digital brokerage, offering agents a more flexible, efficient, and financially compelling model. Its technology platform is reZEN, is a proprietary transaction management and brokerage operations software. The Company’s services include end-to-end transaction management, automated compliance & brokerage oversight, integrated payment & financial services, Leo CoPilot: AI-powered agent support, and open application programming interface (API) for customization.

What is the price predicton of REAX Stock?

Wall Street analysts forecast REAX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for REAX is7.00 USD with a low forecast of 6.00 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Real Brokerage Inc (REAX)'s revenue for the last quarter?

Real Brokerage Inc revenue for the last quarter amounts to 42.16M USD, increased 24.24

What is Real Brokerage Inc (REAX)'s earnings per share (EPS) for the last quarter?

Real Brokerage Inc. EPS for the last quarter amounts to -0.02 USD, decreased -0.00

How many employees does Real Brokerage Inc (REAX). have?

Real Brokerage Inc (REAX) has 474 emplpoyees as of May 10 2026.

What is Real Brokerage Inc (REAX) market cap?

Today REAX has the market capitalization of 437.78M USD.